Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF intra-articular injection for temporomandibular joint osteoarthritis
NL-OMON24620Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous adipose stromal vascular fraction in Temporomandibular Osteoarthritis, sponsored by University Medical Center Groningen. Primary endpoints: Pain and Maximal interincisal mouth opening. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
Temporomandibular Osteoarthritis
Beyond the preview
Go deeper on NL-OMON24620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24620.